Legal & General Group Plc decreased its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 6.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 78,055 shares of the semiconductor company’s stock after selling 4,961 shares during the period. Legal & General Group Plc owned approximately 0.25% of Axcelis Technologies worth $6,271,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in ACLS. Royal Bank of Canada lifted its holdings in shares of Axcelis Technologies by 3.8% in the 1st quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company’s stock valued at $5,838,000 after acquiring an additional 4,324 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Axcelis Technologies by 4.9% in the 1st quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company’s stock valued at $1,774,000 after acquiring an additional 1,678 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Axcelis Technologies by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company’s stock valued at $963,000 after acquiring an additional 849 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Axcelis Technologies by 7.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock valued at $31,560,000 after acquiring an additional 44,275 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Axcelis Technologies by 1.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company’s stock valued at $3,912,000 after acquiring an additional 836 shares during the last quarter. Institutional investors own 89.98% of the company’s stock.
Axcelis Technologies Stock Down 9.1%
Shares of NASDAQ ACLS opened at $147.16 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.59 and a quick ratio of 2.99. The company has a market cap of $4.52 billion, a P/E ratio of 45.84, a PEG ratio of 10.42 and a beta of 1.91. Axcelis Technologies, Inc. has a 1 year low of $61.50 and a 1 year high of $171.61. The firm has a 50-day simple moving average of $134.84 and a two-hundred day simple moving average of $103.37.
Insiders Place Their Bets
In other Axcelis Technologies news, EVP Christopher Tatnall sold 1,166 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $149.75, for a total value of $174,608.50. Following the completion of the sale, the executive vice president owned 27,627 shares of the company’s stock, valued at $4,137,143.25. This trade represents a 4.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Todd Sutton sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $159.99, for a total transaction of $319,980.00. Following the completion of the sale, the vice president directly owned 6,360 shares of the company’s stock, valued at approximately $1,017,536.40. The trade was a 23.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 36,039 shares of company stock valued at $5,461,394 over the last quarter. Corporate insiders own 0.49% of the company’s stock.
Analyst Ratings Changes
A number of research analysts recently commented on ACLS shares. B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price target for the company in a report on Monday, April 20th. Weiss Ratings downgraded shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, May 12th. Finally, Zacks Research raised shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Three analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $116.25.
Read Our Latest Stock Report on Axcelis Technologies
About Axcelis Technologies
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
See Also
- Five stocks we like better than Axcelis Technologies
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
